We introduce Galactosylated CII peptide (CII_259-273-GalHyl₂₆₄) – a key reagent for studying T-cell responses in autoimmune arthritis.

Key Features of the product:

- Immunodominant CII_259-273 epitope with β-D-galactopyranosyl modification at L-hydroxylysine 264 (GalHyl₂₆₄). It is the dominant T-cell epitope in collagen induced arthritis (CIA) in mice.

- Recognized by MHC II Aq, activating autoimmune T-cells.

- Ideal for in vitro T-cell stimulation in antigen-specific recall assays.

More information at: https://www.vacara.se/products_list/gal-peptide/